Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin

Sharraya Aschemeyer, Bo Qiao, D Stefanova, Erika V. Valore, Albert C. Sek, T Alex Ruwe, Kyle R. Vieth, Grace Jung, Carla Casu, Stefano Rivella,

Blood · 2017 · 326 citations · 39 references

DOIFull text

Open access

Concepts

Abstract

oocytes expressing wild-type or K8R Fpn, and mature human red blood cells. We conclude that nonclassical FD is caused by Fpn mutations that decrease hepcidin binding or hinder conformational changes required for ubiquitination and endocytosis of Fpn. The newly documented ability of hepcidin and its agonists to occlude iron transport may facilitate the development of broadly effective treatments for hereditary iron overload disorders.

References

39